Tissue resection system

Information

  • Patent Grant
  • 11666354
  • Patent Number
    11,666,354
  • Date Filed
    Thursday, August 20, 2020
    4 years ago
  • Date Issued
    Tuesday, June 6, 2023
    a year ago
  • Inventors
    • Shener-Irmakoglu; Cemal (Hot Springs, AR, US)
  • Original Assignees
  • Examiners
    • Henderson; Ryan N
    Agents
    • Carter, DeLuca & Farrell LLP
Abstract
A surgical system can include a first instrument defining a first channel and a second instrument receivable by the first channel. The second instrument can include a second channel. A valve coupled to the first instrument controls fluid flow through the first channel. The valve has at least two positions and in one position, the impedance of fluid flow through the valve into the first channel (when the second instrument is not received in the first channel) is substantially the same as when the valve is the other position and the first channel partially blocked by the second instrument. In another aspect, a surgical system can include an outer member and the first instrument can be received within the outer member to define a second channel there between. The first instrument can include a visualization system and an illumination system.
Description
FIELD OF THE INVENTION

This present disclosure relates to a tissue resecting system.


BACKGROUND

Endoscopic surgery of a distensible organ, such as a uterus, may be performed with an endoscope that is insertable into the uterus through the cervix and a resector or other tool that passes through the endoscope to cut or otherwise treat tissue in the uterus. During surgery, it often is desirable to distend the uterus with a fluid, such as saline, sorbitol, or glycine, in order provide a visible working space. Fluid can be infused into the uterus and removed from the uterus through the endoscope and/or the resector.


If the outflow of fluid from the uterus is greater than the inflow of fluid to the uterus, the uterus may collapse back to its normal state, making visualization of the uterus difficult. On the other hand, if the inflow of fluid is greater than the outflow of fluid such that the pressure created by the fluid is greater than the patient's mean arterial pressure, excess fluid can enter the patient's vascular system (known as intravasation), which can lead to serious complications or injury.


The proximal end of the endoscope can include an access port for the working channel into which the resector can be inserted enabling the distal cutting end of the resector to travel through the working channel and beyond the distal end of the endoscope in the uterus to cut or otherwise treat tissue in the uterus. The distention fluid also enters the uterus through the working channel of the endoscope.


The endoscope can be used in two modes, diagnostic mode and operative mode. In diagnostic mode, the endoscope can be used to view inside the uterus in order to identify tissue to be removed or otherwise treated. In diagnostic mode, no resector or other tool is present in the working channel, however distention fluid is driven into the uterus to facilitate observation and diagnosis. In operative mode, the resector or other tool is present in the working channel and impedes the flow of distention fluid through the working channel into the uterus. The insertion or removal of the resector or other tool from the working channel can cause disruptive or dangerous changes in the distention of the uterus.


To avoid this problem, U.S. Pat. Nos. 8,062,214 and 8,419,626 disclose the use of two valves at the access port of the endoscope that can be used to control the flow impedance of distention fluid into the working channel of the endoscope. The first valve can be an on/off valve that controls the flow of distention fluid into the working channel of the endoscope. The second valve can be a two position valve that controls the flow impedance into the working channel. When the second valve is in a first position, the access port is open permitting the resector or other tool can be inserted through the working channel. In addition, second valve can be configured whereby it also allows unimpeded flow of the distention fluid into the working channel where it is impeded by the resector or other tool in the working channel. When the second valve is in a second position, the access port is closed whereby the resector or other tool cannot be inserted into the working channel. However, in the second position, the second valve is configured to allow the distention fluid to flow through a smaller orifice that approximates the impedance produced when the resector or other tool is present in the working channel. As a result, the fluid impedance is substantially the same regardless of whether the resector or other tool is present in the working channel and the position of the second valve which helps to reduce the risks associated with larger changes in distention fluid pressure.


SUMMARY

To aid in addressing these issues, in an aspect of the present disclosure, a surgical system can include a first instrument having a fluid flow channel and a second instrument receivable by the first instrument fluid flow channel. The second instrument can include an aspiration channel. The system can include a valve coupled to the first instrument and configured to control fluid flow through the first instrument channel. The valve can be configured such that impedance of fluid flow through the first instrument channel can be substantially the same without the second instrument received in the first instrument channel and with the first instrument channel partially blocked by the second instrument such that the first instrument channel is limited to a region between the first and second instruments.


Embodiments of this aspect of the present disclosure may include one or more of the following features.


Embodiments of the present present disclosure can be directed to device, such as an endoscope, that can be used to control the distention fluid pressure using a single, multi-position valve. The device can include a working channel extending from a proximal end to a distal end that includes an access port at the proximal end. The access port can be adapted to receive a resector or other tool useful for endoscopic treatment of tissue adjacent the distal end of the device. The proximal end can include a fluidic connection enabling the device to be connected to a source of distention fluid that can be driven into the surgical site (e.g., a uterus) to distend the tissue in the area of the surgical site. A valve can be placed in the fluid path between the fluidic connection and the working channel to control the flow of distention fluid into the working channel.


The valve can have two or more operative positions for controlling the flow of distention fluid into the working channel. In a first position, the valve is open to unrestricted flow of distention fluid into the working channel. In a second position, the valve directs the flow of distention fluid through a flow restricted path into the working channel. The flow restricted path can be configured to produce the same flow impedance as when the resector or other tool is in the working channel. A third position can be provided wherein the valve is closed preventing distention fluid from flowing into the working channel.


In some embodiments, the first instrument can include an outer member and an inner member. The inner member can include a first instrument channel therethrough. The inner member can be received within the outer member, and the outer member and the inner member can define a second fluid flow channel therebetween. The second instrument can include a tube defining a second instrument channel therethrough. The tube partially blocks the first instrument fluid flow channel when received therein. The second fluid flow channel can have a cross-sectional area of, e.g., about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. The first instrument fluid flow channel can have a cross-sectional area of, e.g., about 0.0053 to about 0.0159 square inches, preferably about 0.0106 square inches. The second instrument channel can have a cross-sectional area of, e.g., about 0.0042 to about 0.013 square inches, preferably about 0.0085 square inches.


In some embodiments, the valve can include a housing and a body within the housing. The body defines a flow path therethrough and is moveable relative to the housing between a first position in which the fluid is directed to flow through a first flow path to the first instrument channel and a second position in which the fluid is directed to flow through a second flow path to the first instrument channel. In the first position, the tube of the second instrument tube partially blocks the first instrument fluid flow channel when received therein causing the fluid flow through the first instrument fluid flow channel to be impeded. In the second position, the first instrument fluid flow channel is not impeded by the tube of the second instrument, but the second flow path can be configured to impede fluid flow to the first instrument fluid flow channel such that the fluid flow is about that same as when the tube of the second instrument tube partially blocks the first instrument fluid flow channel. In accordance with some embodiments of the present disclosure, the impedance produced by the second flow path can be adjustable. In accordance with some embodiments of the present disclosure, the impedance produced by the second flow path can be changed by changing or replacing a structure of the second flow path.


The system can include a pump and the first instrument is configured to connect to the pump such that the pump infuses fluid through the first instrument channel. The pump can be programmed to infuse fluid through the first instrument channel to maintain a substantially constant pressure of between about 60 mm Hg and about 120 mm Hg inside a distensible organ. A sensor coupled to the pump can sense a flow impedance at a given flow rate, and a controller coupled to the sensor and the pump can compare the flow impedance to a predetermined flow impedance for the given flow rate to verify the identity of the first and second instruments.


The second instrument channel can be in fluid communication with a source of suction and a regulator can be interposed between the second instrument channel and the source of suction to regulate an amount of suction applied through the second instrument channel.


According to another aspect of the present disclosure, a method of regulating inflow through a valve includes positioning the valve in a first position directing the inflow along a path having a first impedance of flow into a working channel and positioning the valve in a second position directing the inflow along a path having a second impedance of flow into the working channel; and introducing a surgical instrument inserting the surgical instrument into the working channel. When the valve is in the first position and the surgical instrument is inserted into the working channel the impedance of flow into the working channel is about the same as the impedance of flow into the working channel when the valve is in the second position and the surgical instrument is removed from the working channel.


According to another aspect of the present disclosure, an apparatus for surgery can include an outer member and an inner member received within the outer member. The outer member and the inner member can define a first channel therebetween. The inner member can include an optical lens and can define a second channel for receiving a surgical instrument. The first and second channels can be configured such that a pump having an inflow rate of up to about 0.7 L/min connected to the second channel can maintain fluid pressure inside an organ.


Embodiments of this aspect can include one or more of the following features. A pump can be coupled to the second channel to introduce fluid through the second channel at an inflow rate up to about 0.7 L/min. The outer member can include a plurality of holes in fluid communication with the first channel. The plurality of holes can be positioned in a distal portion of the outer member. The second channel can include a D-shaped cross-section. The first channel can have a cross-sectional area, e.g., of about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. The second channel can have a cross-sectional area of, e.g., about 0.0053 to about 0.0159 square inches, preferably about 0.0106 square inches. The second channel can receive the surgical instrument therethrough. The surgical instrument can include a suction channel with a cross-sectional area of, e.g., about 0.0042 to about 0.013 square inches, preferably about 0.0085 square inches. A valve can be coupled to the inner member for regulating inflow through one of two or more pathways to the second channel such that inflow through a first pathway when the surgical instrument is received in the second channel has an impedance equal to the impedance through the second pathway when the surgical instrument is removed from the second channel.


According to another aspect of the present disclosure, a method includes infusing fluid into a distensible organ, and maintaining a substantially constant fluid pressure inside the distensible organ between about 60 mm Hg and about 120 mm Hg.


According to another aspect of the present disclosure, a system can include an endoscope defining a channel therethrough and a surgical instrument received within the endoscope channel. The surgical instrument can include a channel therein for connection with a source of suction. A regulator can be coupled to the surgical instrument channel between the instrument channel and the source of suction to regulate an amount of suction applied through the instrument channel.


Additional aspects of the present disclosure will be apparent to those of ordinary skill in the art in view of the detailed description of various implementations, which is made with reference to the drawings, a brief description of which is provided below.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 shows a schematic diagram of a resection system according to some embodiments of the present disclosure.



FIG. 2A shows an exploded, perspective view of a hysteroscope of the system of FIG. 1.



FIG. 2B shows a perspective view of the assembled hysteroscope of FIG. 2A.



FIG. 3A shows a longitudinal cross-sectional view of the hysteroscope of FIG. 2B.



FIG. 3B shows a cross-sectional view of the hysteroscope of FIG. 2B taken along line 3B-3B.



FIG. 4 shows a perspective view of the hysteroscope of FIG. 2B with a resector received therethrough.



FIG. 5 shows a cross-sectional view of the hysteroscope and resector of FIG. 4 taken along line 5-5.



FIG. 6 shows a diagrammatic view of a valve in a first position according to some embodiments of the present disclosure.



FIG. 7 shows a diagrammatic view of a valve in a second position according to some embodiments of the present disclosure.



FIG. 8 shows a diagrammatic view of a valve in a third position according to some embodiments of the present disclosure.



FIG. 9 shows a schematic diagram of a fluid management system of the resection system of FIG. 1.



FIG. 10 shows a perspective view of an obturator for use with a sheath of the hysteroscope of FIG. 2A.



FIGS. 11-13 show the obturator, hysteroscope and resector in use.



FIG. 14 shows a graph showing the impedance through the hysteroscope at various flow rates.





DETAILED DESCRIPTION

The present disclosure is directed to a method and a system for endoscopically resecting tissue in a distended organ. The system can include a valve that enables the impedance to the inflow of distention fluid through the system into the distended organ to be maintained substantially the same, even as surgical instruments are inserted and removed from the endoscope during the surgical procedure. Maintaining an even distention pressure can be beneficial to the patient in that it can help to reduce the risks of over distention and intravasation and help to keep the surgical procedure as short as possible.


Referring to FIG. 1, the illustrative embodiment of the tissue resecting system 10 according to some embodiments of the present disclosure includes an endoscope, e.g., hysteroscope 100, having a distal portion 102 insertable into a distensible organ, e.g., a uterus, of a patient 20 to flow fluid into and remove fluid from the organ. The hysteroscope 100 can be connectable to fluid bags 17 (mounted on a cart 15 by an inflow line 30 to deliver fluid to the hysteroscope 100. In accordance with some embodiments, the inflow line 30 runs through a pump, e.g., peristaltic pump 310, of a fluid management control unit 300 on cart 15. The fluid management control unit 300 and/or the Pump 310 control the pressure of the fluid delivered along inflow line 30 to hysteroscope 100. System 10 can also be connectable to a gravity container 40 on cart 15 connected by an outflow line 32 to an outflow port 105 on hysteroscope 100 to collect the outflow of fluid from hysteroscope 100, under the force of gravity. In accordance with some embodiments, the outflow line 32 is optionally connected to a surgical drape 22 to collect fluid from patient 20 in gravity container 40.


As shown in the illustrative embodiment, system 10 includes a resector 200 that can be received within hysteroscope 100 during use to resect tissue from the organ. The resector 200 in this embodiment includes a handle 205 and a distal portion 210 that extends out of distal portion 102 of hysteroscope 100. Distal portion 210 includes a working end 220, e.g., a morcellator that can be actuated to cut tissue from the organ. In this embodiment, handle 205 includes a motor (not shown) coupled to working end 220 to rotate working end 220 about a longitudinal axis to cut tissue. Also, optionally located on cart 15 is a resector control unit 60 of system 10 connected by a wire 64 to resector 200 to control movement of working end 220. In this embodiment, system 10 includes a foot-pedal 62 connected to control unit 60 by a wire 64 to actuate control unit 60.


Also, optionally located on cart 15 is one or more vacuum containers 42 of system 10 connected by suction line 34 to a suction port 230 on resector 200 to collect fluid and tissue suctioned through resector 200. In this embodiment, at least one of vacuum containers 42 includes a tissue trap 43 that collects tissue suctioned through suction lines 34 for later examination, e.g., by a pathologist. In this embodiment, system 10 also includes a vacuum regulator 400 connected by a suction line 36 to vacuum containers 42 and by vacuum line 38 to a vacuum source (not shown) to regulate suction provided by the vacuum source through suction channel 204 of resector 200.


Also, optionally located on cart 15 is a fluid monitoring unit 18 of system 10 that tracks the amount of fluid collected in gravity container 40 and vacuum containers 42 and the amount of fluid pumped by fluid management control unit 300 and can be configured to set off an audible and/or visual alarm if the difference between the amounts of fluid pumped and collected is above a threshold value, thus minimizing the possibility of excess fluid intravasation.


In this embodiment, part of system 10 includes a visualizing and imaging assembly 50 that includes a camera 51 coupled to a camera port 106 of hysteroscope 100, and a light source 52 coupled by a fiber optic cable 54 to a light port 109 of hysteroscope 100. Together, camera 50 and light source 52 allow a user to remotely visualize the tissue at distal end 102 of hysteroscope 100. In this embodiment, assembly 50 also includes an imaging station 70 connected by a fiber optic cable 56 to camera 50. Imaging station 70 includes one or more monitors 72 for viewing images from camera 50 and a capture system 74 for making a recording of the images.


Referring to FIGS. 2A and 2B, hysteroscope 100 optionally includes a sheath 80 that has a tube 120 with an inner wall 122 defining a channel 121 therethrough. In this embodiment, distal end 102 of tube 120 includes a plurality of holes 112 in communication with channel 121 for allowing fluid to flow out of an organ through channel 121. In this embodiment, sheath 80 has a proximal portion 84 that includes outflow port 105. In this embodiment, outflow port 105 is in fluid communication with channel 121. An on/off valve 123 is optionally positioned between outflow port 105 and channel 121 for turning on and off fluid flow from channel 121 to outflow port 105.


In this embodiment, hysteroscope 100 includes a scope housing 90 that has an elongated member 124 removably receivable in tube 120. Member 124 includes an outer wall 126 and an inner wall 125. In this embodiment, inner wall 125 defines an inflow channel 130. A proximal portion 94 of scope housing 90 includes inflow port 110, and a valve 150 which are fluidly connected to inflow channel 130, as described below. Member 124 also defines a lens channel 140 that houses an optical lens 142. Scope housing 90 includes a proximal portion 94 that includes camera port 106 and light port 109, which are coupled to optical lens 142 by fiber optic lines (not shown). Light travels from light port 109 to distal end 102 of hysteroscope 100 to illuminate objects near distal end 102. Light for images of those objects are received by optical lens 142, and travel through camera port 106 to camera (FIG. 1), to allow the user to view the organ through hysteroscope 100. This configuration enables lens channel 140 to be positioned adjacent to inflow channel 130 to help keep optical lens 142 clear of debris during use. Proximal portion 94 of scope housing 90 optionally includes a pin 92 receivable in a J-shaped slot (not shown) in sheath 80 to releasably lock scope housing 90 to sheath 80 when member 124 is received in tube 120.


Referring also to FIGS. 3A and 3B, when member 124 is received in tube 120, inner wall 122 of tube 120 and outer wall 126 of member 124 define a passive outflow channel 128 therebetween. Passive outflow channel 128 can be divided into a left portion 128A and a right portion 128B, which reconnect at outflow port 105. In this embodiment, passive outflow channel 128 is in fluid communication with holes 112 in distal end 102 of tube 120 and with outflow port 105 to permit passive outflow of fluid from the organ under the force of gravity. It will be understood that outflow channel 128 need not be divided. Inner wall 125 of member 124 defines inflow channel 130 in fluid communication with an aperture 108 in distal end 102 of hysteroscope 100 to permit fluid flow into the organ. Fluid can flow through passive outflow channel 128 along a path that is completely separate from a path along which fluid flows through inflow channel 130.


Referring to FIG. 3B, inflow channel 130 and passive outflow channel 128 can be sized and configured so that fluid management control unit 300, which has an inflow rate of up to 0.7 L/min, is able to maintain a substantially constant fluid pressure inside a distensible organ by pumping sufficient fluid into the organ through inflow channel 130 to balance fluid flow out of the organ through passive outflow channel 128, as described below. For example, inflow channel 130 can be configured to have a D-shaped cross-section with a cross-sectional area, e.g., of about 0.0153 to about 0.0461 square inches, preferably about 0.0307 square inches, and each portion 128A, 128B of passive outflow channel 128 can have a crescent-shaped cross-section with a combined cross-sectional area, e.g., of about 0.0083 to about 0.0249 square inches, preferably about 0.0166 square inches. It should be understood that other configurations and sizes of inflow channel 130 and passive outflow channel 128 can be used, so long as outflow of fluid through outflow channel 128 does not exceed the ability of fluid management control unit 300 to pump fluid into the organ through inflow channel 130 at least at the same flow rate as the outflow of fluid.


Referring to FIGS. 4 and 5, in this embodiment, resector 200 includes a stationary elongated outer tube 202 and a rotatable inner tube 201 that is coupled to working end 220 (not shown). Inflow channel 130 receives resector 200 therethrough. In this embodiment, the cross-section of inflow channel 130 is selected such that inflow channel 130 can be only partially blocked by resector 200, allowing fluid to continue to flow into the organ through a region of inflow channel 130 unblocked by resector 200, located between inner wall 125 and elongated tube 202. In this embodiment, inner tube 201 of resector 200 defines a suction channel 204 having an opening 206 at working end 220 of resector 200 and in fluid communication with suction port 230 of resector handle 205 (FIG. 1) to permit suction of fluid and tissue from the organ. Fluid is drawn through suction channel 204 along a path that is completely separate from the paths along which fluid flows through outflow channel 128 and inflow channel 130.


Referring to FIG. 5, passive outflow channel 128, inflow channel 130, and suction channel 204 can be sized and configured so that fluid management control unit 300 maintains the substantially constant fluid pressure inside the organ by pumping sufficient fluid into the organ to balance fluid flow out of the organ through passive outflow channel 128 and suction of fluid out of the organ through suction channel 204, as described below. For example, in this embodiment, the portion of inflow channel 130 not blocked by resector 200 has a cross-sectional area of about 0.0106 square inches, passive outflow channel 128 has a cross-sectional area of about 0.0166 square inches, and suction channel 204 has a cross-sectional area of about 0.0085 square inches. It should be understood that other configurations and sizes of inflow channel 130, passive outflow channel 128, and suction channel 204 can be used, so long as outflow of fluid through outflow channel 128 and suction of fluid through suction channel 204 do not exceed the ability of fluid management control unit 300 to pump fluid into the organ through inflow channel 130 at the same flow rate as the outflow of fluid.


The ability of fluid management control unit 300 to maintain a substantially constant fluid pressure in the organ can be further facilitated by valve 150 of scope housing 90, which maintains substantially the same fluid flow impedance through inflow channel 130 regardless of whether resector 200 is positioned in scope housing 90. For example, FIG. 14 shows the impedance through hysteroscope 100 at various flow rates, regardless of whether resector 200 is positioned in scope housing 90. By maintaining a substantially constant fluid flow impedance, valve 150 facilitates fluid management control unit maintaining a substantially constant pressure in the organ regardless of whether resector 200 is positioned in scope housing 90. Impedance refers to the pressure drop in fluid between two points (in this case between inflow port 110 and the distal end of inflow channel 130) and varies proportional to the square of the flow rate.



FIGS. 6-8 show diagrammatic views of valve 150 located at the proximal end of the housing of the hysteroscope 100. In this embodiment, the valve 150 includes an inlet port 110 enabling the hysteroscope 100 to be connected to a source of fluid (not shown). In this embodiment, the valve 150 includes a valve body 152 that can rotate within the valve housing 154 to control the flow of fluid into the inflow channel 130. In this embodiment, the valve body 152 includes one or more channels 156 that connect one or more parts of the hysteroscope 100. In this embodiment, the valve body 152 includes a valve handle 153 to enable the user to move the valve body 152 between positions. In the first position, the valve body channel 156 connects the inlet port 110 to the channel 160 such that fluid supplied at the inlet port 110 flows through channel 160 into the inflow channel 130. In the second position, the valve body channel 156 connects the inlet port 110 to the calibration line 158. The calibration line 158 connects the valve body 154 to the channel 160 that is connected to the inflow channel 130. The calibration line 158 can be selected to have a predefined impedance to fluid flow that is substantially the same as the impedance to fluid flow when the valve body 152 is in the first position and the resector 200 is positioned in the inflow channel 130. In this embodiment, the impedance of the calibration line 158 is determined by the diameter of a portion of the calibration line or a flow restricting mechanism can be part of the calibration line 158. In accordance with some embodiments, the impedance of the calibration line 158 is, optionally, adjusted by adjusting the flow restricting mechanism or by replacing at least a portion of the calibration line 158 with a portion having a larger or smaller diameter. As shown in FIGS. 6-8, the inflow channel 130 extends proximally from the proximal portion 94 of the hysteroscope 100 and include an access port 162 into which the resector 200 can be inserted. In accordance with some embodiments, the access port 162 is optionally fitted with a seal 164 which allows the resector 200 to be inserted and removed and minimizes leakage of fluid through the access port 162. The seal 164 can be formed of an expandable material (e.g., rubber, silicone, PDMS) that can expand when the resector 200 is inserted in to the inflow channel 130, and contracts and remains closed after the resector 200 is removed. In accordance with some embodiments of the present disclosure, the access port 162 optionally includes a valve (not shown) that closes the proximal end of the inflow channel 130 when resector 200 is not present.



FIG. 6 shows a diagrammatic view of a valve 150 in a first position according to some embodiments of the present disclosure. In accordance with some embodiments of the present disclosure, the valve 150 in the first position is configured to allow the maximum fluid flow into the fluid flow channel. In the first position, the inlet port 110 is connected to channel 160 which directs fluid flow into the inlet channel 130. In this embodiment, the valve 150 provides the maximum flow and minimum impedance to fluid flow through the inlet channel 130.



FIG. 7 shows a diagrammatic view of a valve 150 in a second position according to some embodiments of the present disclosure. In accordance with some embodiments of the present disclosure, the valve 150 in the second position is configured to provide impeded fluid flow, at about the same impedance as when the resector 200 is inserted into the inflow flow channel 130. In the second position, the inlet port 110 is connected to calibration line 158 which directs fluid flow through the calibration line 158 and into the inlet channel 130. In this embodiment, the valve 150 provides calibrated fluid flow that matches the impedance to fluid flow when the resector 200 is received in the inflow channel 130. In operation, the user can place the valve 150 into the second position prior to inserting or removing the resector 200 to prevent a spike of excess fluid and pressure into the uterus during surgery. This reduces the risk of harm to the patient from intravasation.



FIG. 8 shows a diagrammatic view of a valve in a third position according to some embodiments of the present disclosure. In accordance with some embodiments of the present disclosure, the valve 150 in the third position can be configured to block fluid flow into channel 160 and the inflow channel 130 (e.g., this can be the “off” position). In the third position, the inlet port 110, calibration line 158 and channel 160 can each be closed by the valve body 152 such that no fluid can flow in the inlet port 110 or out via channel 160 or the calibration line 158.


In some embodiments of the present disclosure, fluid management control unit 300 is used to maintain substantially constant fluid pressure inside the organ by pumping sufficient fluid into the organ through inflow channel 130 to balance fluid flow out of the organ through passive outflow channel 128 and from suction of fluid through suction channel 204 (when resector 200 is received in hysteroscope 100). Referring to FIG. 9, fluid management control unit 300 optionally includes a peristaltic pump 310 through which runs fluid line 30 that transmits fluid from fluid bag 17 to inflow port 110 of hysteroscope 100. Pump 310 pumps fluid along fluid line 30, controlling the pressure and flow rate of fluid transmitted to hysteroscope 100.


Fluid management control unit 300 optionally also includes a flow rate sensor 315, such as a roller head, a turbine, or an ultrasonic sensor, that measures the flow rate of fluid outputted by pump 310. Control unit 300 optionally also includes a pressure sensor, e.g., pressure transducer 320 that senses the fluid pressure in fluid line 30 after the fluid passes through pump 310. In this embodiment, fluid management control unit 300 includes an input 345 where a user can input a desired pressure to be maintained inside the organ, and a memory 340 that contains information on the impedance (i.e., pressure drop) through the hysteroscope 100 and resector 200 combination at a range of different flow rates.


Coupled to pressure sensor 320, pump 310, flow rate sensor 315, input 345, and memory 340, is a controller 330, e.g., a microprocessor, that controls the pressure and the flow rate outputted by pump 310 based on the flow rate measured by flow rate sensor 315, the pressure measured by pressure sensor 320, the information stored in memory 340, and the target pressure 345. Based on a measured flow rate and a measured pressure, controller 330 determines the actual pressure in the organ according to the information stored in memory 340 that accounts for the impedance (i.e., pressure drop) through the hysteroscope 100 at various flow rates. Controller 330 then compares the pressure in the organ with the target pressure and adjusts the pressure and flow rate outputted by pump 310 accordingly. If the target pressure is greater than the actual pressure, then controller 330 increases the output of pump 310. If the target pressure is less than the actual pressure, then controller 330 decreases the output of pump 310.


The size and configuration of inflow channel 130, passive outflow channel 128, and suction channel 204 facilitate controller 330 maintaining substantially constant pressure in the organ. In addition, valve 150 facilitates maintaining a substantially constant pressure in the organ by keeping the impedance through hysteroscope 100 the same regardless of whether resector 200 is received in hysteroscope 100. Thus, it is not necessary for controller 330 to “know” whether resector 200 is positioned in hysteroscope 100. Fluid management control unit 300 is able to maintain a relatively constant pressure of fluid within the organ, e.g., at a preset pressure between about 60 mm Hg and about 120 mm Hg.


Fluid management control unit 300 can also include a feature that verifies that a correct combination of hysteroscope 100 and resector 200 is being used (i.e., to ensure that the system is only used when a resector and a hysteroscope having properly balanced flow channels are attached to fluid management control unit 300). Memory 340 contains flow rate and impedance information for each valid combination of a hysteroscope and a resector. Controller 330 is programmed to determine whether the pressure measured by pressure transducer 320 is within a threshold value of a predetermined pressure for a given flow rate in order to verify the identity of the combination of the hysteroscope and the resector. Controller 330 is coupled to a shut-off circuit 360 to disable pump 310 when controller 330 determines that the combination of hysteroscope and resector is invalid (e.g., when an incorrect size resector is used with the hysteroscope). If the combination is verified, then controller 330 overrides shut-off circuit 360 and allows pump 310 to pump fluid to hysteroscope 100, as described above. On the other hand, if controller 330 determines that the combination of the hysteroscope and the resector is invalid (e.g., wrong size resector), the controller 330 activates shut-off circuit 360 to disable pump 310. Controller 330 also is coupled to an alarm 350, e.g., a visual or audible alarm that is activated when pump 310 is disabled. Controller 330 is programmed to make pressure comparisons at several (e.g., three or four) flow rates prior to use of hysteroscope 100 and resector 200.


In use, a user can assemble the components of the resection system 10 as shown in FIG. 1. As shown in FIGS. 6 and 7, the user can position valve 150 to the first position. The user can insert the resector 200 through hysteroscope 100. The user can verify the combination of hysteroscope 100 and resector 200 by activating fluid management control unit 300, as described above with respect to FIG. 9, to infuse fluid through hysteroscope 100 and resector 200 assembly at three or four different flow rates, to sense the flow impedance through the assembly, and to compare each sensed flow impedance to predetermined flow impedances. If the combination is verified, the user removes resector 200 from hysteroscope 100, and moves valve 150 to the second position, as shown in FIG. 7.


Referring to FIG. 10, to position sheath 80 within the uterus, system 10 includes an obturator 800 insertable through sheath 80 when scope housing 90 is removed from sheath 80. Obturator 800 includes a shaft 810, a sharp, distal tip 820, and a proximal handle 840. Disposed between handle 840 and shaft 810 is a pin 830 that fits into the J-shaped slot (not shown) in sheath 80 to removably lock obturator 800 to sheath 80.


Referring to FIG. 11, with obturator 800 received within sheath 80 such that tip 820 extends beyond distal portion 102 of sheath 80, the user inserts obturator 800 and sheath 80 into a uterus 900. Referring to FIG. 12, the user removes obturator 800 from sheath 80, and inserts scope housing 90 through sheath 80 and into uterus 900. The user then moves valve 150 to the second position, as shown in FIG. 7, and activates fluid management control system 300 to pump fluid through channel 130 of hysteroscope 100 and into uterus 900 along flow path B, at a first impedance, to distend uterus 900, as shown in FIG. 12. At the same time, the user allows fluid to flow out of uterus 900 via holes 112 and channel 122 in hysteroscope 100 along flow path C to gravity container 40, in order to keep the pressure inside uterus 900 between about 60 mm Hg and 120 mm Hg.


Once uterus 900 has been distended, with valve 150 in the second position, as shown in FIG. 7, the user inserts resector 200 through the access port 162 and inflow channel 130 of hysteroscope 100, and into uterus 900, as shown in FIG. 13 and positions valve 150 to the first position, as shown in FIG. 6. Fluid management control system 300 continues to pump fluid so that fluid flows through inflow channel 130, between inner wall 125 and resector 200 and into uterus 900 at a second impedance substantially equal to the first impedance. At the same time, the user allows fluid to flow out of uterus 900 via holes 112 and channel 128 in hysteroscope along flow path C and suctions fluid out of uterus 900 through resector 200 along flow path D, in order to keep the pressure inside uterus 900 between about 60 mm Hg and 120 mm Hg. Fluid suctioned along path D is collected in vacuum containers 42. The user also can actuate vacuum regulator 400 to control the amount of suction through resector 200 along path D. Preferably, the user maintains the vacuum pressure above approximately 100 mm Hg (to facilitate tissue removal) and below approximately 200 mm Hg (to inhibit uterus collapse). In order to inhibit uterus collapse, vacuum regulator 400 is preset to not allow vacuum pressure greater than a threshold value, e.g., 200 mm Hg, to be applied.


The user visualizes the inside of uterus 900 on monitors 72 of visualizing and imaging assembly 50. The user actuates foot pedal 62, which activates resector control unit 60. Resector control unit 60 activates resector 200, e.g., by rotating a cutting blade 910 at working end 220 of resector 200, to cut tissue from uterus 900. Fluid and tissue cut by blade 910 are suctioned through channel 204 of resector 200 along path D. During the procedure, resector 200 can be removed from hysteroscope 100 while hysteroscope 100 remains inside uterus 900, e.g., to clean resector 200 or change instruments, so long as the user moves valve 150 to the second position, as shown in FIG. 7, while removing resector 200 to limit the inflow of fluid through channel 130 of hysteroscope 100.


During the procedure, fluid monitor unit 18 can track the amount of fluid infused through resector 200 and the amount of fluid collected in gravity container 40 and vacuum containers 42. Fluid monitor unit 18 can set off an audible or a visual alarm if substantially more fluid is infused than collected, which indicates that the patient is absorbing too much fluid. Once the procedure is complete, the user can close valve 150 by moving it to the third position, as shown in FIG. 8, and removing resector 200 and hysteroscope 100 from uterus 900.


A number of embodiments of the present disclosure have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the present disclosure. For example, the shape, size, and configuration of the fluid flow channels through the hysteroscope and the resector could be different than that shown and described, such as having an inflow channel with an elliptical, square, triangular, or trapezoidal cross-section. Instead of a blind bore, the body of the secondary valve could include a peripheral channel formed in an outer surface of the body. Instead of a secondary valve, the primary valve could be electronically controlled to maintain a constant impedance through the hysteroscope regardless of whether the resector is inserted through the hysteroscope. The hysteroscope can be used with other types of resector tools having rotatable working ends, such as burrs or drills. The hysteroscope also can be used with a resector tool having a reciprocating working end, such as the instrument disclosed in U.S. Pat. No. 7,510,563 entitled “Reciprocating rotary arthroscopic surgical instrument,” the entirety of which is incorporated herein by reference. The fluid management system can include another type of pump, such as a centrifugal, piston, or diaphragm pump. The vacuum regulator could include a manually or electronically operable valve, a flow sensor, and/or a pressure gauge. The devices shown can be used for surgery on other distensible organs, such as a shoulder or knee joint. Different combinations of the components of the system could be used or components could be added or deleted. These and other embodiments are within the scope of the following claims.


Other embodiments are within the scope and spirit of the present disclosure. For example, due to the nature of software, functions described above can be implemented using software, hardware, firmware, hardwiring, or combinations of any of these. Features implementing functions may also be physically located at various positions, including being distributed such that portions of functions are implemented at different physical locations.


Each of the above concepts and obvious variations thereof is contemplated as falling within the spirit and scope of the claimed invention, which is set forth in the following claims.

Claims
  • 1. A hysteroscope comprising: an access port defining a fluid flow channel and configured to receive an instrument through the fluid flow channel;a valve inlet configured to receive a fluid;a valve housing operably coupled to the valve inlet;a valve body defining a body channel, the valve body movable within the valve housing at least between a first open position and a second open position; anda valve channel in fluid communication with the fluid flow channel of the access port;wherein when the valve body is: in the first open position, a first flow path provides a first impedance to fluid flow from the valve inlet through the body channel of the valve body and through a first opening in the valve housing to the fluid flow channel of the access port; andin the second open position, a second flow path provides a second impedance to fluid flow from the valve inlet through the body channel of the valve body, through a second opening in the valve housing and through a calibration line to the fluid flow channel of the access port,wherein fluid is prevented from flowing through the calibration line when the valve is in the first open position.
  • 2. The hysteroscope according to claim 1, wherein a third impedance to flow is produced when an instrument is received within the fluid flow channel of the access port, wherein the third impedance is substantially the same as the second impedance when an instrument is not received within the fluid flow channel of the access port and the valve body is in the second open position.
  • 3. The hysteroscope according to claim 1, wherein the valve body has a closed position wherein fluid flow is blocked from passing through the valve housing when the valve body is in the closed position.
  • 4. The hysteroscope according to claim 1, further comprising a seal operably coupled to a proximal portion of the access port, the seal configured to reduce fluid flow out of the access port.
  • 5. The hysteroscope according to claim 1, wherein a distal portion of the access port is disposed on a proximal portion of the hysteroscope.
  • 6. The hysteroscope according to claim 1, further comprising the calibration line, wherein the calibration line defines a calibration channel in fluid communication with the second opening in the valve housing and the fluid flow channel of the access port.
  • 7. The hysteroscope according to claim 1, wherein the valve inlet is configured to operably couple to a pump such that the pump causes fluid to flow through the fluid flow channel of the access port.
  • 8. A surgical system comprising: a hysteroscope including an access port operably coupled to the hysteroscope, the access port defining a fluid flow channel configured to receive an instrument through the fluid flow channel; anda valve operably coupled to the hysteroscope, the valve including: a valve inlet configured to receive a fluid;a valve housing operably coupled to the valve inlet;a valve body defining a body channel, the valve body movable within the valve housing at least between a first open position and a second open position; anda valve channel in fluid communication with the fluid flow channel of the access port;wherein when the valve body is:in the first open position, a first flow path provides a first impedance to fluid flow from the valve inlet through the body channel of the valve body and through a first opening in the valve housing to the fluid flow channel of the access port; andin the second open position, a second flow path provides a second impedance to fluid flow from the valve inlet through the body channel of the valve body, through a second opening in the valve housing and through a calibration line to the fluid flow channel of the access port,wherein fluid is prevented from flowing through the calibration line when the valve is in the first open position.
  • 9. The surgical system according to claim 8, wherein a third impedance to flow is produced when an instrument is received within the fluid flow channel of the access port, wherein the third impedance is substantially the same as the second impedance when an instrument is not received within the fluid flow channel of the access port and the valve body is in the second open position.
  • 10. The surgical system according to claim 8, wherein the valve body has a closed position wherein fluid flow is blocked from passing through the valve housing when the valve body is in the closed position.
  • 11. The surgical system according to claim 8, further comprising a seal operably coupled to a proximal portion of the access port, the seal configured to reduce fluid flow out of the access port.
  • 12. The surgical system according to claim 8, wherein a distal portion of the access port is operably coupled to a proximal portion of the hysteroscope.
  • 13. The surgical system according to claim 8, wherein the valve includes the calibration line and the calibration line defines a calibration channel in fluid communication with the second opening in the valve housing and the fluid flow channel of the access port.
  • 14. The surgical system according to claim 8, further comprising a pump coupled to the valve inlet such that the pump causes fluid to flow through the fluid flow channel of the access port.
  • 15. The surgical system according to claim 14, wherein the pump is programmed to cause fluid to flow through the fluid flow channel of the access port to maintain a substantially constant pressure of between about 60 mm Hg and about 120 mm Hg inside a distensible organ.
  • 16. The surgical system according to claim 14, further comprising a sensor coupled to the pump to sense a flow impedance at a given flow rate and a controller coupled to the sensor and the pump to compare the flow impedance to a predetermined flow impedance for the given flow rate.
  • 17. The surgical system according to claim 16, wherein the sensor is configured to identify an instrument positioned through the access port based on the sensed flow impedance.
CROSS REFERENCE TO RELATED APPLICATION

The present application is a continuation application of U.S. patent application Ser. No. 15/544,985, filed on Jul. 20, 2017, which is a U.S. National Stage Application under 35 U.S.C. § 371(a) of PCT/US2015/013356 filed Jan. 28, 2015, the entire contents of each of which are incorporated by reference herein.

US Referenced Citations (271)
Number Name Date Kind
1585934 Muir May 1926 A
1666332 Hirsch Apr 1928 A
1831786 Duncan Nov 1931 A
2708437 Hutchins May 1955 A
3297022 Wallace Jan 1967 A
3686706 Finley Aug 1972 A
3734099 Bender et al. May 1973 A
3791379 Storz Feb 1974 A
3812855 Banko May 1974 A
3835842 Iglesias Sep 1974 A
3850162 Iglesias Nov 1974 A
3945375 Banko Mar 1976 A
3980252 Tae Sep 1976 A
3995619 Glatzer Dec 1976 A
3996921 Neuwirth Dec 1976 A
4011869 Seiler, Jr. Mar 1977 A
4108182 Hartman et al. Aug 1978 A
4146405 Timmer et al. Mar 1979 A
4198958 Utsugi Apr 1980 A
4203444 Bonnell et al. May 1980 A
4210146 Banko Jul 1980 A
4246902 Martinez Jan 1981 A
4247180 Norris Jan 1981 A
4258721 Parent et al. Mar 1981 A
4261346 Wettermann Apr 1981 A
4294234 Matsuo Oct 1981 A
4316465 Dotson, Jr. Feb 1982 A
4369768 Vukovic Jan 1983 A
4392485 Hiltebrandt Jul 1983 A
4414962 Carson Nov 1983 A
4449538 Corbitt et al. May 1984 A
4493698 Wang et al. Jan 1985 A
4517977 Frost May 1985 A
4543965 Pack et al. Oct 1985 A
4567880 Goodman Feb 1986 A
4589414 Yoshida et al. May 1986 A
4601284 Arakawa et al. Jul 1986 A
4601290 Effron et al. Jul 1986 A
4606330 Bonnet Aug 1986 A
4630598 Bonnet Dec 1986 A
4644952 Patipa et al. Feb 1987 A
4649919 Thimsen et al. Mar 1987 A
4700694 Shishido Oct 1987 A
4706656 Kuboto Nov 1987 A
4718291 Wood et al. Jan 1988 A
4737142 Heckele Apr 1988 A
4749376 Kensey et al. Jun 1988 A
4756309 Sachse et al. Jul 1988 A
4819635 Shapiro Apr 1989 A
4844064 Thimsen et al. Jul 1989 A
4850354 McGurk-Burleson et al. Jul 1989 A
4856919 Takeuchi et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4924851 Ognier et al. May 1990 A
4940061 Terwilliger et al. Jul 1990 A
4950278 Sachse et al. Aug 1990 A
4955882 Hakky Sep 1990 A
4986827 Akkas et al. Jan 1991 A
4998527 Meyer Mar 1991 A
4998914 Wiest et al. Mar 1991 A
5007917 Evans Apr 1991 A
5027792 Meyer Jul 1991 A
5037386 Marcus et al. Aug 1991 A
5105800 Takahashi et al. Apr 1992 A
5106364 Hayafuji et al. Apr 1992 A
5112299 Pascaloff May 1992 A
5116868 Chen et al. May 1992 A
5125910 Freitas Jun 1992 A
5133713 Huang et al. Jul 1992 A
5152744 Krause et al. Oct 1992 A
5158553 Berry et al. Oct 1992 A
5163433 Kagawa et al. Nov 1992 A
5169397 Sakashita et al. Dec 1992 A
5176677 Wuchinich Jan 1993 A
5195541 Obenchain Mar 1993 A
5226910 Kajiyama et al. Jul 1993 A
5244459 Hill Sep 1993 A
5254117 Rigby et al. Oct 1993 A
5269785 Bonutti Dec 1993 A
5270622 Krause Dec 1993 A
5275609 Pingleton et al. Jan 1994 A
5288290 Brody Feb 1994 A
5304118 Trese et al. Apr 1994 A
5312399 Hakky et al. May 1994 A
5312425 Evans et al. May 1994 A
5312430 Rosenbluth et al. May 1994 A
5320091 Grossi et al. Jun 1994 A
5347992 Pearlman et al. Sep 1994 A
5350390 Sher Sep 1994 A
5364395 West, Jr. Nov 1994 A
5374253 Burns, Sr. et al. Dec 1994 A
5390585 Ryuh Feb 1995 A
5392765 Muller Feb 1995 A
5395313 Naves et al. Mar 1995 A
5403276 Schechter et al. Apr 1995 A
5409013 Clement Apr 1995 A
5409453 Lundquist et al. Apr 1995 A
5411513 Ireland et al. May 1995 A
5421819 Edwards et al. Jun 1995 A
5425376 Banys et al. Jun 1995 A
5429601 Conley et al. Jul 1995 A
5435805 Edwards et al. Jul 1995 A
5443476 Shapiro Aug 1995 A
5449356 Walbrink et al. Sep 1995 A
5456673 Ziegler et al. Oct 1995 A
5456689 Kresch et al. Oct 1995 A
5483951 Frassica et al. Jan 1996 A
5490819 Nicholas et al. Feb 1996 A
5490860 Middle et al. Feb 1996 A
5492537 Vancaillie Feb 1996 A
5498258 Hakky et al. Mar 1996 A
5527331 Kresch et al. Jun 1996 A
5549541 Muller Aug 1996 A
5556378 Storz et al. Sep 1996 A
5563481 Krause Oct 1996 A
5569164 Lurz Oct 1996 A
5569254 Carlson et al. Oct 1996 A
5569284 Young et al. Oct 1996 A
5575756 Karasawa et al. Nov 1996 A
5591187 Dekel Jan 1997 A
5601583 Donahue et al. Feb 1997 A
5601603 Illi Feb 1997 A
5602449 Krause et al. Feb 1997 A
5603332 O'Connor Feb 1997 A
5630798 Beiser et al. May 1997 A
5649547 Ritchart et al. Jul 1997 A
5669927 Boebel et al. Sep 1997 A
5672945 Krause Sep 1997 A
5674179 Bonnet et al. Oct 1997 A
5676497 Kim Oct 1997 A
5695448 Kimura et al. Dec 1997 A
5702420 Sterling et al. Dec 1997 A
5709698 Adams et al. Jan 1998 A
5730752 Alden et al. Mar 1998 A
5733298 Berman et al. Mar 1998 A
5741286 Recuset Apr 1998 A
5741287 Alden et al. Apr 1998 A
5749885 Sjostrom et al. May 1998 A
5749889 Bacich et al. May 1998 A
5759185 Grinberg Jun 1998 A
5772634 Atkinson Jun 1998 A
5775333 Burbank et al. Jul 1998 A
5782849 Miller Jul 1998 A
5807240 Muller et al. Sep 1998 A
5807282 Fowler Sep 1998 A
5810770 Chin et al. Sep 1998 A
5810861 Gaber Sep 1998 A
5814009 Wheatman Sep 1998 A
5833643 Ross et al. Nov 1998 A
5840060 Beiser et al. Nov 1998 A
5857995 Thomas et al. Jan 1999 A
5873886 Larsen et al. Feb 1999 A
5899915 Saadat May 1999 A
5911699 Anis et al. Jun 1999 A
5911722 Adler et al. Jun 1999 A
5913867 Dion Jun 1999 A
5916229 Evans Jun 1999 A
5925055 Adrian et al. Jul 1999 A
5928163 Roberts et al. Jul 1999 A
5944668 Vancaillie et al. Aug 1999 A
5947990 Smith Sep 1999 A
5951490 Fowler Sep 1999 A
5956130 Vancaillie et al. Sep 1999 A
5957832 Taylor et al. Sep 1999 A
6001116 Heisler et al. Dec 1999 A
6004320 Casscells et al. Dec 1999 A
6007513 Anis et al. Dec 1999 A
6024751 Lovato et al. Feb 2000 A
6032673 Savage et al. Mar 2000 A
6039748 Savage et al. Mar 2000 A
6042552 Cornier Mar 2000 A
6068641 Varsseveld May 2000 A
6086542 Glowa et al. Jul 2000 A
6090094 Clifford, Jr. et al. Jul 2000 A
6090123 Culp et al. Jul 2000 A
6113594 Savage Sep 2000 A
6119973 Galloway Sep 2000 A
6120147 Vijfvinkel et al. Sep 2000 A
6120462 Hibner et al. Sep 2000 A
6132448 Perez et al. Oct 2000 A
6149633 Maaskamp Nov 2000 A
6156049 Lovato et al. Dec 2000 A
6159160 Hsei et al. Dec 2000 A
6159209 Hakky Dec 2000 A
6203518 Anis et al. Mar 2001 B1
6217543 Anis et al. Apr 2001 B1
6224603 Marino May 2001 B1
6244228 Kuhn et al. Jun 2001 B1
6258111 Ross et al. Jul 2001 B1
6277096 Cortella et al. Aug 2001 B1
6315714 Akiba Nov 2001 B1
6358200 Grossi Mar 2002 B1
6358263 Mark et al. Mar 2002 B2
6359200 Day Mar 2002 B1
6402701 Kaplan et al. Jun 2002 B1
6428486 Ritchart et al. Aug 2002 B2
6471639 Rudischhauser et al. Oct 2002 B2
6494892 Ireland et al. Dec 2002 B1
6585708 Maaskamp Jul 2003 B1
6610066 Dinger et al. Aug 2003 B2
6626827 Felix et al. Sep 2003 B1
6632182 Treat Oct 2003 B1
6656132 Ouchi Dec 2003 B1
6712773 Viola Mar 2004 B1
6824544 Boebel et al. Nov 2004 B2
6837847 Ewers et al. Jan 2005 B2
7025720 Boebel et al. Apr 2006 B2
7025732 Thompson et al. Apr 2006 B2
7150713 Shener et al. Dec 2006 B2
7226459 Cesarini et al. Jun 2007 B2
7249602 Emanuel Jul 2007 B1
7510563 Cesarini et al. Mar 2009 B2
7763033 Gruber et al. Jul 2010 B2
7922737 Cesarini et al. Apr 2011 B1
8061359 Emanuel Nov 2011 B2
8062214 Shener et al. Nov 2011 B2
8419626 Shener-Irmakoglu et al. Apr 2013 B2
8663264 Cesarini et al. Mar 2014 B2
8678999 Isaacson Mar 2014 B2
8852085 Shener-Irmakoglu et al. Oct 2014 B2
8893722 Emanuel Nov 2014 B2
8932208 Kendale et al. Jan 2015 B2
8951274 Adams et al. Feb 2015 B2
9060800 Cesarini et al. Jun 2015 B1
9060801 Cesarini et al. Jun 2015 B1
9066745 Cesarini et al. Jun 2015 B2
9072431 Adams et al. Jul 2015 B2
9089358 Emanuel Jul 2015 B2
9125550 Shener-Irmakoglu et al. Sep 2015 B2
9155454 Sahney et al. Oct 2015 B2
10772652 Shener-Irmakoglu Sep 2020 B2
20010039963 Spear et al. Nov 2001 A1
20010047183 Privitera et al. Nov 2001 A1
20020058859 Brommersma May 2002 A1
20020165427 Yachia et al. Nov 2002 A1
20030050603 Todd Mar 2003 A1
20030050638 Yachia et al. Mar 2003 A1
20030078609 Finlay et al. Apr 2003 A1
20030114875 Sjostrom Jun 2003 A1
20040082915 Kadan Apr 2004 A1
20040204671 Stubbs et al. Oct 2004 A1
20050043690 Todd Feb 2005 A1
20050085692 Kiehn et al. Apr 2005 A1
20060036132 Renner et al. Feb 2006 A1
20060047185 Shener Mar 2006 A1
20060241586 Wilk Oct 2006 A1
20060293560 Nguyen Dec 2006 A1
20070238928 Maseda Oct 2007 A1
20080015621 Emanuel Jan 2008 A1
20080058588 Emanuel Mar 2008 A1
20080058842 Emanuel Mar 2008 A1
20080097468 Adams et al. Apr 2008 A1
20080097469 Gruber et al. Apr 2008 A1
20080097470 Gruber Apr 2008 A1
20080097471 Adams et al. Apr 2008 A1
20080135053 Gruber et al. Jun 2008 A1
20080146872 Gruber et al. Jun 2008 A1
20080146873 Adams et al. Jun 2008 A1
20080245371 Gruber Oct 2008 A1
20080249366 Gruber et al. Oct 2008 A1
20080249534 Gruber et al. Oct 2008 A1
20080249553 Gruber et al. Oct 2008 A1
20080262308 Prestezog et al. Oct 2008 A1
20090088600 Meloul Apr 2009 A1
20100087798 Adams et al. Apr 2010 A1
20100152647 Shener et al. Jun 2010 A1
20110166419 Reif et al. Jul 2011 A1
20120078038 Sahney et al. Mar 2012 A1
20130131452 Kuroda et al. May 2013 A1
20140031834 Germain et al. Jan 2014 A1
20190388162 Azizian Dec 2019 A1
Foreign Referenced Citations (70)
Number Date Country
3206381 Sep 1983 DE
3339322 May 1984 DE
3601453 Sep 1986 DE
3615694 Nov 1987 DE
4038398 Jun 1992 DE
4440035 May 1996 DE
19633124 May 1997 DE
19751632 Sep 1999 DE
102006022827 Dec 2006 DE
0310285 Apr 1989 EP
0327410 Aug 1989 EP
0557044 Aug 1993 EP
0582295 Feb 1994 EP
0606531 Jul 1994 EP
0621008 Oct 1994 EP
0806183 Nov 1997 EP
1681022 Jul 2006 EP
2093353 Sep 1982 GB
2311468 Oct 1997 GB
H0175416 May 1989 JP
2002529185 Sep 2002 JP
2002538889 Nov 2002 JP
2003245247 Sep 2003 JP
1006944 Mar 1999 NL
8101648 Jun 1981 WO
9211816 Jul 1992 WO
9307821 Apr 1993 WO
9315664 Aug 1993 WO
9426181 Nov 1994 WO
9505777 Mar 1995 WO
9510981 Apr 1995 WO
9510982 Apr 1995 WO
9522935 Aug 1995 WO
9530377 Nov 1995 WO
9611638 Apr 1996 WO
9626676 Sep 1996 WO
9709922 Mar 1997 WO
9717027 May 1997 WO
9719642 Jun 1997 WO
9724071 Jul 1997 WO
9734534 Sep 1997 WO
9735522 Oct 1997 WO
9809569 Mar 1998 WO
9846147 Oct 1998 WO
9903407 Jan 1999 WO
9903409 Jan 1999 WO
9907295 Feb 1999 WO
9911184 Mar 1999 WO
9939648 Aug 1999 WO
9944506 Sep 1999 WO
9960935 Dec 1999 WO
9012010 Mar 2000 WO
9028890 May 2000 WO
0033743 Jun 2000 WO
0044295 Aug 2000 WO
0047116 Aug 2000 WO
0057797 Oct 2000 WO
0135831 May 2001 WO
0158368 Aug 2001 WO
0195810 Dec 2001 WO
02069808 Sep 2002 WO
03022164 Mar 2003 WO
03077767 Sep 2003 WO
2005060842 Jul 2005 WO
2005096963 Oct 2005 WO
2006105283 Oct 2006 WO
2006121968 Nov 2006 WO
2006121970 Nov 2006 WO
2007044833 Apr 2007 WO
2012044705 Apr 2012 WO
Related Publications (1)
Number Date Country
20200375624 A1 Dec 2020 US
Continuations (1)
Number Date Country
Parent 15544985 US
Child 16998038 US